137 related articles for article (PubMed ID: 3713449)
1. Ether lipid derivatives: antineoplastic activity in vitro and the structure-activity relationship.
Berdel WE; Von Hoff DD; Unger C; Schick HD; Fink U; Reichert A; Eibl H; Rastetter J
Lipids; 1986 Apr; 21(4):301-4. PubMed ID: 3713449
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
Schick HD; Berdel WE; Fromm M; Fink U; Jehn U; Ulm K; Reichert A; Eibl H; Unger C; Rastetter J
Lipids; 1987 Nov; 22(11):904-10. PubMed ID: 3444383
[TBL] [Abstract][Full Text] [Related]
3. Elimination of leukemic cells by the combined use of ether lipids in vitro.
Okamoto S; Olson AC; Vogler WR
Cancer Res; 1987 May; 47(10):2599-603. PubMed ID: 3471316
[TBL] [Abstract][Full Text] [Related]
4. Ether lipids and analogs in experimental cancer therapy. A brief review of the Munich experience.
Berdel WE
Lipids; 1987 Nov; 22(11):970-3. PubMed ID: 3328030
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of the alkyl-linked lipoidal amine 4-aminomethyl-1-[2,3-(di-n-decyloxy)-n-propyl]-4-phenylpiperidine (CP-46,665) in cells from human tumors and leukemias.
Berdel WE; Schick HD; Fink U; Reichert A; Ulm K; Rastetter J
Cancer Res; 1985 Mar; 45(3):1206-13. PubMed ID: 3971369
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
Unger C; Eibl H; Kim DJ; Fleer EA; Kötting J; Bartsch HH; Nagel GA; Pfizenmaier K
J Natl Cancer Inst; 1987 Feb; 78(2):219-22. PubMed ID: 3468284
[TBL] [Abstract][Full Text] [Related]
7. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro.
Berdel WE; Korth R; Reichert A; Houlihan WJ; Bicker U; Nomura H; Vogler WR; Benveniste J; Rastetter J
Anticancer Res; 1987; 7(6):1181-7. PubMed ID: 3442414
[TBL] [Abstract][Full Text] [Related]
8. Comparison of selective cytotoxicity of alkyl lysophospholipids.
Vogler WR; Olson AC; Okamoto S; Shoji M; Raynor RL; Kuo JF; Berdel WE; Eibl H; Hajdu J; Nomura H
Lipids; 1991 Dec; 26(12):1418-23. PubMed ID: 1819744
[TBL] [Abstract][Full Text] [Related]
9. Antineoplastic activity of the thioether lysophospholipid derivative BM 41.440 in vitro.
Fromm M; Berdel WE; Schick HD; Fink U; Pahlke W; Bicker U; Reichert A; Rastetter J
Lipids; 1987 Nov; 22(11):916-8. PubMed ID: 3444385
[TBL] [Abstract][Full Text] [Related]
10. The differential susceptibility of A427 and A549 cell lines to the growth-inhibitory effects of ET-18-OCH3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids.
Lu X; Arthur G
Cancer Res; 1992 May; 52(10):2813-7. PubMed ID: 1581895
[TBL] [Abstract][Full Text] [Related]
11. Clonogenicity of normal and malignant hematopoietic progenitor cells after exposure to synthetic alkyl-lymphospholipids.
Dulisch I; Neumann HA; Löhr GW; Andreesen R
Blut; 1985 Dec; 51(6):393-9. PubMed ID: 3865693
[TBL] [Abstract][Full Text] [Related]
12. Effect of lipid derivatives on invasion in vitro and on surface glycoproteins of three rodent cell types.
Storme GA; Bruyneel EA; Schallier DC; Bolscher JG; Berdel WE; Mareel MM
Lipids; 1987 Nov; 22(11):847-50. PubMed ID: 3444376
[TBL] [Abstract][Full Text] [Related]
13. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines.
Civoli F; Daniel LW
Cancer Chemother Pharmacol; 1998; 42(4):319-26. PubMed ID: 9744778
[TBL] [Abstract][Full Text] [Related]
14. Noncytotoxic alkyl-lysophospholipid treatment increases sensitivity of leukemic K562 cells to lysis by natural killer (NK) cells.
Botzler C; Kolb HJ; Issels RD; Multhoff G
Int J Cancer; 1996 Mar; 65(5):633-8. PubMed ID: 8598315
[TBL] [Abstract][Full Text] [Related]
15. Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Small GW; Strum JC; Daniel LW
Lipids; 1997 Jul; 32(7):715-23. PubMed ID: 9252959
[TBL] [Abstract][Full Text] [Related]
16. Early and selective induction of apoptosis in human leukemic cells by the alkyl-lysophospholipid ET-18-OCH3.
Mollinedo F; Martínez-Dalmau R; Modolell M
Biochem Biophys Res Commun; 1993 Apr; 192(2):603-9. PubMed ID: 8484770
[TBL] [Abstract][Full Text] [Related]
17. Influence of the alkyllysophospholipid ET-18-OCH3 on methylnitrosourea-induced rat mammary carcinomas.
Berger MR; Munder PG; Schmähl D; Westphal O
Oncology; 1984; 41(2):109-13. PubMed ID: 6538675
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo cytotoxicity of alkyl lysophospholipid ET-18-OCH3 and thioether lipid BM 41.440.
Leder GH; Fiebig HH; Wallbrecher E; Winterhalter BR; Löhr GW
Lipids; 1987 Nov; 22(11):958-61. PubMed ID: 3444393
[TBL] [Abstract][Full Text] [Related]
19. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
20. Syntheses of racemic and nearly optically pure ether lipids and evaluation of in vitro antineoplastic activities.
Duclos RI; Chia HH; Abdelmageed OH; Esber H; Fournier DJ; Makriyannis A
J Med Chem; 1994 Nov; 37(24):4147-54. PubMed ID: 7990114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
